Science first
We start with the evidence and build the market story from there.
About MAG Pharma
A global outlook.
A local commitment.
We help healthcare innovators navigate the real work between a strong product and meaningful local adoption.
Our evolution
Built to make good innovation matter here.
MAG Pharma began with a clear idea: innovative products need more than distribution to succeed in Australia and New Zealand. They need local understanding, regulatory discipline and trusted relationships.
Today, our portfolio spans molecular allergy diagnostics, allergen immunotherapy, contact allergy testing and connected clinical workflows.
This evolving portfolio lets us build deep relationships with partners, clinicians and laboratories while remaining open to new products and opportunities.
Our principles
Clarity in the work. Care in the relationship.
We value practical thinking, transparent communication and responsible progress.
Locally grounded
ANZ regulation, clinical practice and customer realities shape every plan.
Long-term partnership
We stay close through launch, adoption and the full product lifecycle.
A message from our founder
Progress is built together.
Our ambition is to build a thoughtful portfolio—one where every product is represented with care, conviction and a genuine understanding of the people and professional workflows it is designed to serve.
As MAG Pharma grows, we remain committed to strong partnerships, new possibilities and making global innovation work locally.
Our local presence
Across Australia and New Zealand.
Two local bases, one connected ANZ approach.
Melbourne
Suite 535, 1 Queens Road
Melbourne VIC 3004
Auckland
Unit 28, 90 Hobsonville Road
Hobsonville, Auckland 0618
Work with us